This topic contains a solution. Click here to go to the answer

Author Question: The loss of estrogen and progesterone at menopause does not reduce sexual desire in most women. ... (Read 136 times)

Lobcity

  • Hero Member
  • *****
  • Posts: 524
The loss of estrogen and progesterone at menopause does not reduce sexual desire in most women.
 
  a. True
  b. False

Question 2

Which pituitary hormone stimulates uterine contractions during labor?
 
  A) Luteinizing hormone
  B) Oxytocin
  C) Prolactin
  D) Gonadotropic releasing hormone



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

carolinefletcherr

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

a

Answer to Question 2

B




Lobcity

  • Member
  • Posts: 524
Reply 2 on: Jun 22, 2018
:D TYSM


xoxo123

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library